rs 2234693 | rs 9340799 | SLE patients (n = 30) (%) | Control subjects (n = 20) (%) | OR | 95% CI | P value |
---|---|---|---|---|---|---|
TT | AA | 2 | 5 | 1 | reference | |
TT | AG | 0 | 2 | 0.4 | 0.01–12.9 | 0.63 |
TT | GG | 1 | 3 | 0.83 | 0.05–13.6 | 0.89 |
TC | AA | 8 | 2 | 10 | 1.04–95.4 | 0.04* |
TC | AG | 2 | 4 | 1.25 | 0.11–13.2 | 0.85 |
TC | GG | 4 | 1 | 10 | 0.64–154.4 | 0.09 |
CC | AA | 0 | 2 | 0.4 | 0.01–12.9 | 0.63 |
CC | AG | 6 | 0 | 28.6 | 1.1–731.5 | 0.04* |
CC | GG | 7 | 1 | 17.5 | 1.2–250.3 | 0.03* |